MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.phymed.2024.155960

Медицинская библиотека · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024

Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial.

Lin Luoqi, Xiao Jingmin, Wu Lei, Fan Feiting, Feng Wenjie, Wei Jun, Wang Guangen, Liu Gang, Zhang Wei, Lu Yun, Li Yunhui, Lu Lijun, Li Huimin, Sun Shengde, Gou Jian, Dang Yuqi, Sun Xuwu, Jiang Baihua, Qin Jiangbo, Zhen Hui, Fang Yun, Ding Junping, Huang Minling, Zhao Wenhan, Cai Yan, Huang Kaifeng, Tong Xiaoping, Chen Yuanbin, Zhang Hongchun, Lin Lin

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Alleviating the sore throat caused by acute pharyngitis is a primary patient concern. However, antibiotics are not commonly recommended drugs, and abuse can lead to serious consequences such as drug resistance. Therefore, seeking alternative treatments is necessary.

PURPOSE: To investigate the efficacy and safety of Kegan Liyan (KGLY) oral liquid for patients with acute pharyngitis.

STUDY

DESIGN

Randomized, double-blinded, placebo-controlled, multi-center study.

METHODS

Participants from 17 hospitals were randomly assigned 1:1 to receive KGLY oral liquid or placebo for five days. Assessments occurred at baseline, day 3, and day 6. The primary outcome was the recovery rate. Secondary outcomes included sore throat and cough visual analogue scale (VAS), the area under the curve (AUC) of sore throat VAS, time to sore throat relief and recovery, proportion of participants with sore throat relief and recovery, traditional Chinese medicine (TCM) syndrome score, single TCM manifestation score and use of acetaminophen.

RESULTS

Involving 239 participants (120 in KGLY and 119 in placebo group), the study found a significantly higher recovery rate on day 6 in the KGLY group (between-group difference, 27.20 % [15.00 % to 39.40 %], p < 0.001). On day 3 and 6, the KGLY group showed significantly larger reductions in sore throat (-3.02 vs -2.37, p = 0.001; -4.66 vs -3.64, p < 0.001) and cough VAS scores (-1.55 vs -1.05, p = 0.004; -2.28 vs -1.56, p < 0.001) from baseline. KGLY oral liquid lowered the AUC of sore throat VAS score (-2.33 [-4.10 to -0.56], p = 0.011), shortened time to sore throat recovery (hazard ratio, 0.42 [0.30 to 0.59], p < 0.001), increased sore throat recovery rate at day 6 (75.00 % vs 42.86 %, p < 0.001), decreased the TCM syndrome score (-2.03 [-2.69 to -1.37], p < 0.001), and improved individual TCM symptoms compared to placebo. No significant differences between the groups in acetaminophen usage. KGLY oral liquid was safe and tolerated.

CONCLUSION

KGLY oral liquid may be a beneficial and safe alternative treatment for acute pharyngitis, which can alleviate symptoms such as sore throat, swollen throat, cough, and phlegm production.

Для цитирования: Lin Luoqi, Xiao Jingmin, Wu Lei, Fan Feiting, Feng Wenjie, Wei Jun, Wang Guangen, Liu Gang, Zhang Wei, Lu Yun, Li Yunhui, Lu Lijun, Li Huimin, Sun Shengde, Gou Jian, Dang Yuqi, Sun Xuwu, Jiang Baihua, Qin Jiangbo, Zhen Hui, Fang Yun, Ding Junping, Huang Minling, Zhao Wenhan, Cai Yan, Huang Kaifeng, Tong Xiaoping, Chen Yuanbin, Zhang Hongchun, Lin Lin. Efficacy and safety of Kegan Liyan oral liquid for patients with acute pharyngitis: A randomized, double-blinded, placebo-controlled, multi-center trial.. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2024. DOI: 10.1016/j.phymed.2024.155960.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.